- Medical and
- Recreational
Cannabis Testing Market size was valued at USD 1,088.98 million in 2023 and poised grow to at a significant CAGR of 13.2% from 2024-2030. The cannabis testing market is being propelled forward by rising demand for cannabis legalization for medical purposes in a number of countries, as well as the establishment of Laboratory Information Management Systems (LIMS) in cannabis testing laboratories. Collaborations between large corporations are also likely to contribute to market growth. The cannabis testing industry is predicted to increase in emerging economies throughout LATAM (Latin America) and MEA (the Middle East and Africa). Compared to other regions, this is primarily due to significant government backing for medical marijuana legalization in these countries. This is drawing several investors, notable players, and government organizations to invest in developing cannabis testing laboratory standards or improving their operations and activity. Cannabis testing laboratories are focusing on expanding their services, which provides enormous opportunities for these labs to gain a more customer base and enhance revenue. CannaSafe plans to develop into a number of states beyond California, such as Oregon, Florida, and Illinois, in the near future.
Medical cannabis segment is anticipated to show the moderate growth rate during forecast period, and this can be due to growing interest among pharma companies to incorporate cannabis into medicinal products, as cannabis has potential opportunities to treat wide range of diseases like anxiety, epilepsy, pain management, arthritis, sleep disorders, and others. The recreational segment holds the highest share. The expanding number of licences for recreational cannabis dealers and distributors for a wide range of items like as herbal teas, edibles, and other adult-use cannabis is responsible for the recreational segment's large proportion. Demand is also one of the variables that has allowed recreational cannabis to gain a significant market share.
Study Period
2024-2030Base Year
2023CAGR
13.2%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
The entire market is being driven by the growing demand for cannabis legalization for medical purposes in numerous nations. In addition, increasing research on various medical use of cannabis and growing number of cannabis testing laboratories in various emerging markets are also key factors driving the cannabis testing market. Lack of uniformity in quality standards and high cost of laboratory equipment, are major impediments to the cannabis testing market.
By Product Type
By Geography
The global cannabis testing market size was valued at US$ 1,088.98 million in 2023 and is projected to grow at a CAGR of 13.2% from 2024 to 2030.
Restek Corporation, Digipath, Inc, Sigma-Aldrich,Detection Technology Plc.
The Asia Pacific is the fastest-growing region for the cannabis testing market
1.Executive Summary |
2.Global Cannabis Testing Market Introduction |
2.1.Global Cannabis Testing Market - Taxonomy |
2.2.Global Cannabis Testing Market - Definitions |
2.2.1.Type |
2.2.2.Region |
3.Global Cannabis Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Cannabis Testing Market Analysis, 2019-2023 and Forecast 2024-2030 |
4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Cannabis Testing Market By Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
5.1. Medical |
5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Recreational |
5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6.Global Cannabis Testing Market By Region, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
6.1. North America |
6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Europe |
6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Asia Pacific (APAC) |
6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Middle East and Africa (MEA) |
6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Latin America |
6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.North America Cannabis Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
7.1. Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.1.1.Medical |
7.1.2.Recreational |
7.2. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
7.2.1.United States of America (USA) |
7.2.2.Canada |
8.Europe Cannabis Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
8.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Medical |
8.1.2.Recreational |
8.2. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Germany |
8.2.2.France |
8.2.3.Italy |
8.2.4.United Kingdom (UK) |
8.2.5.Spain |
8.2.6.Rest of EU |
9.Asia Pacific (APAC) Cannabis Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
9.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Medical |
9.1.2.Recreational |
9.2. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.China |
9.2.2.India |
9.2.3.Australia and New Zealand (ANZ) |
9.2.4.Japan |
9.2.5.Rest of APAC |
10.Middle East and Africa (MEA) Cannabis Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Medical |
10.1.2.Recreational |
10.2. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.GCC Countries |
10.2.2.South Africa |
10.2.3.Rest of MEA |
11.Latin America Cannabis Testing Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Medical |
11.1.2.Recreational |
11.2. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Brazil |
11.2.2.Mexico |
11.2.3.Rest of LA |
12. Competition Landscape |
12.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
12.2.1.Agilent Technologies, Inc. |
12.2.2.Detection Technology Plc. |
12.2.3.Shimadzu Corporation |
12.2.4.Merck KGaA |
12.2.5.Restek Corporation. |
12.2.6.Digipath, Inc |
12.2.7.Waters Corporation. |
12.2.8.Sigma-Aldrich |
12.2.9.Accelerated Technology Laboratories, Inc. |
13. Research Methodology |
14. Appendix and Abbreviations |